Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term protection. If this yearly injection is approved and widely implemented, it ...

SCIENTISTS have said that human-induced climate change increased the severity of the 2021-2022 drought in the Horn of Africa.

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...